↓ Skip to main content

Metastatic renal cell cancer treatments: An indirect comparison meta-analysis

Overview of attention for article published in BMC Cancer, January 2009
Altmetric Badge

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Metastatic renal cell cancer treatments: An indirect comparison meta-analysis
Published in
BMC Cancer, January 2009
DOI 10.1186/1471-2407-9-34
Pubmed ID
Authors

Edward J Mills, Beth Rachlis, Chris O'Regan, Lehana Thabane, Dan Perri

Abstract

Treatment for metastatic renal cell cancer (mRCC) has advanced dramatically with understanding of the pathogenesis of the disease. New treatment options may provide improved progression-free survival (PFS). We aimed to determine the relative effectiveness of new therapies in this field.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Hungary 1 2%
Unknown 54 96%

Demographic breakdown

Readers by professional status Count As %
Other 9 16%
Researcher 9 16%
Student > Master 8 14%
Student > Bachelor 4 7%
Student > Doctoral Student 4 7%
Other 11 20%
Unknown 11 20%
Readers by discipline Count As %
Medicine and Dentistry 32 57%
Engineering 3 5%
Mathematics 2 4%
Nursing and Health Professions 2 4%
Biochemistry, Genetics and Molecular Biology 1 2%
Other 4 7%
Unknown 12 21%